Action NBY NOVABAY PHARMACEUTICALS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues NovaBay Pharmaceuticals, Inc.

Actions

NBY

US66987P4090

Marché Fermé - Nyse
Autres places de cotation
 22:10:00 16/07/2024 		Varia. 5j. Varia. 1 janv.
2,14 USD -0,93 % Graphique intraday de NovaBay Pharmaceuticals, Inc. -6,96 % -70,03 %
11/07 Novabay Pharmaceuticals, Inc. fournit des prévisions de chiffre d'affaires pour l'année 2024 CI
01/07 NovaBay Pharmaceuticals et Eyenovia commencent leurs activités de co-promotion MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day
NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
Novabay Pharmaceuticals, Inc. Provides Revenue Guidance for the Year 2024
Novabay Pharmaceuticals Reports Preliminary Revenue Results for the Second Quarter and First Half of 2024
NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions
NovaBay Pharmaceuticals, Eyenovia Begin Co-Promotion Deal Activities
NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
NovaBay Pharmaceuticals, Inc. and Eyenovia, Inc. Commence Co-Promotion Activities
NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions
NovaBay Files Registration Statement on Behalf of Selling Shareholders
NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American
NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates
NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms
NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Earnings Flash (NBY) NOVABAY PHARMACEUTICALS Reports Q1 Revenue $2.63M, vs. Street Est of $3.28M
NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action NBY
  4. Actualités NovaBay Pharmaceuticals, Inc.
  5. Autres langues